FOR IMMEDIATE RELEASE
CONTACT: Anne Bell
301-998-6785 | email@example.com
NIPER Project Director, Dr. R. Srinivas (left), and USP Senior Vice President-Global Sites, Koduru Surendranath, Ph.D. (right), agree to academic exchange focused on pharmaceutical expertise building while Indian President Pranab Mukherjee looks on. (Photo courtesy of President's Secretariat and National Informatics Center)
Hyderabad India, December 1, 2016 — President Pranab Mukherjee honored the U.S. Pharmacopeial Convention (USP) partnership with the National Institutes for Pharmaceutical Education and Research (NIPER) recently.
During a ceremony at Rashtrapati Bhavan, President Mukherjee pointed to the importance of academic and industry partnerships to industrial quality and to India’s future. “The higher education sector has a crucial role in the national developmental effort,” explained President Mukherjee. “The quality of training provided to students employed by this sector determines the level of industrial competence.”
This prestigious recognition came during the Second Visitor’s conference, just weeks after USP and NIPER-Hyderabad formalized an academic exchange program that began informally eight years ago, shortly after USP opened offices in Hyderabad. The program is designed to build pharmaceutical expertise and promote innovation and collaboration between industry and academia by giving students hands on experience in industry settings. For USP, it furthers the company’s mission of improving public health worldwide by advancing public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods.
“India is a leading manufacturer of generics medicine globally, with a growing percentage designated for export to the US and other countries, and increased exports are translating into increased pressure on Indian manufacturers to use international standards of quality,” said Koduru V. Surendranath, Ph.D, USP Senior Vice President – Global Sites. “By investing through this exchange program in India’s pharmaceutical expertise and capacity for quality assurance, USP is in effect investing in improved quality of medicines globally.”
Media inquiries may be directed to firstname.lastname@example.org.